HealthRetatrutide Shows 25% Weight Loss in Phase 3 Trial
Retatrutide, an experimental weekly injection for weight loss, helped obese participants lose up to 25% of their body weight after 80 weeks in a Phase 3 clinical trial. This promising result positions retatrutide as a potential rival to Ozempic in obesity treatment.
NDTV·




